Novartis Lifts Annual Sales and Profit Guidance Signaling Confidence in Growth MANE Q1 2026 Earnings EPS Misses Estimates by Wide Margin as PreRevenue Biotech Continues RD Investment Karnatakas Fiscal Strain Deepens as Welfare Spending Drives Annual Borrowing Surge of 20000 Crore